Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy

Journal of Clinical Oncology

Volumn 31, Issue 17, 2013, Pages 2123-2127

  Chan, Arlene ^a   Su, Charles ^c   De Boer, Richard H ^d   Gajdatsy, Adam ^b  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^d Epworth Freemasons Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; IOHEXOL; ANTINEOPLASTIC AGENT; TAXOID;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLEPHARITIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CORNEA DISEASE; DACRYOCYSTOGRAPHY; EARLY CANCER; EPIPHORA; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INCIDENCE; LACRIMAL DUCT OCCLUSION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PREVALENCE; PRIORITY JOURNAL; SYMPTOM ASSESSMENT; VISUAL DISORDER; X-RAY COMPUTED TOMOGRAPHY; ADJUVANT CHEMOTHERAPY; BREAST NEOPLASMS; CHEMICALLY INDUCED; LACRIMAL GLAND DISEASE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DEXAMETHASONE; FEMALE; HUMANS; INCIDENCE; LACRIMAL APPARATUS DISEASES; LACRIMAL DUCT OBSTRUCTION; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; TAXOIDS;

EID: 84890456327     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.6574     Document Type: Article

References (16)

1. Griffin JD, Garnick MB: Eye toxicity of cancer chemotherapy: A review of the literature. Cancer 48:1539-1549, 1981
2. Vizel M, Oster MW: Ocular side effects of cancer chemotherapy. Cancer 49:1999-2002, 1982
3. Eiseman AS, Flanagan JC, Brooks AB, et al: Ocular surface, ocular adnexal and lacrimal complications associated with the use of systemic 5-fluorouracil. Ophthal Plast Reconstr Surg 19:216-224, 2003
4. Stevens A, Spooner D: Lacrimal duct stenosis and other ocular toxicity associated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy for early stage breast cancer. Clin Oncol (R Coll Radiol) 13:438-440, 2001
5. Esmaeli B, Hidaji L, Adinin RB, et al: Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy. Cancer 98:504-507, 2003
6. Lee V, Bentley CR, Olver JM: Sclerosing canaliculitis after 5-fluorouracil breast cancer chemotherapy. Eye (Lond) 12:343-349, 1998
7. Hassan A, Hurwitz JJ, Burkes RL: Epiphora in patients receiving systemic 5-fluorouracil therapy. Can J Ophthalmol 33:14-19, 1998
8. Brink HM, Beex LV: Punctal and canalicular stenosis associated with systemic fluorouracil therapy: Report of five cases and review of the literature. Doc Ophthalmol 90:1-6, 1995
9. Esmaeli B, Amin S, Valero V, et al: Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel. J Clin Oncol 24:3619-3622, 2006
10. De Laurentiis M, Cancello G, D’agostino D, et al: Taxane-based combinations as adjuvant chemotherapy of early breast cancer: A meta-analysis of randomized trials. J Clin Oncol 26:44-53, 2008
11. Martín M, Seguí M, Antón A, et al: Adjuvant docetaxel for high-risk, node-negative breast cancer. N Engl J Med 363:2200-2210, 2010
12. Spell DW, Estephan FF, Lin JT, et al: Epiphora induced by intermittent docetaxel (Taxotere) in patients with non-small cell lung cancer. Cancer Invest 21:550-552, 2003
13. Kintzel PE, Michaud LB, Lange MK, et al: Docetaxel-associated epiphora. Pharmacotherapy 26:853-867, 2006
14. Martin M, Pienkowski T, Mackey J, et al: Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352:2302-2313, 2005
15. Eiermann W, Pienkowski T, Crown J, et al: Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial. J Clin Oncol 29: 3877-3884, 2011
16. Sparano JA, Wang M, Martino S, et al: Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 358:1663-1671, 2008